Image
user avatar
BioNTech SE
@BioNTech_Group
Our vision: Harnessing the immune system’s power to turn science into survival. Data Privacy: bit.ly/4fdYEf6 Imprint: bit.ly/3YmtoUr
Mainz, Germany
biontech.com
Joined November 2018
162
Following
79.6K
Followers
Posts
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Mar 13, 2023
    Bye bye Europe, hello Africa! The containers for our 1st BioNTainer just arrived in Kigali after a bit more than 24 hours of traveling by truck and plane. Thank you to H.E. President @PaulKagame, his ministers and teams as well as honorable guests. investors.biontech.de/news-releases/…
    Image
    143K
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Jan 11, 2021
    We are honored that our co-founders Dr. Ugur Sahin and Dr. Özlem Türeci are featured on the cover of @TIME this week. The accompanying article provides an inside look at BioNTech, our peers, and the science behind the COVID-19 vaccines developed around the world.
    user avatar
    TIME
    @TIME
    Jan 11, 2021
    TIME's new global cover: Inside the vaccine revolution ti.me/3qdaNYj
    Image
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Jun 23, 2022
    We’re honored to have welcomed our African partners for the first time on the African continent as construction began for the initial African #mRNA manufacturing facility in Kigali, Rwanda, 4 months after we introduced the #BioNTainer concept in February. investors.biontech.de/news-releases/…
    Image
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Dec 2, 2020
    Exciting news: We received the world’s first authorization of a #COVID19 #vaccine, with @MHRA granting emergency use authorization in the UK. More regulatory decisions may come in 2020. More information: gov.uk/government/new…
    Image
    00:00
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Dec 21, 2022
    The six containers comprising our #BioNTainer for our first planned manufacturing facility in Africa were produced in Europe, underwent quality checks and are being prepared for shipment to Kigali, Rwanda, where they are expected to arrive in Q1 2023. investors.biontech.de/news-releases/…
    Image
    00:00
    254K
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Feb 1, 2022
    We initiated a rolling submission for an amendment to the #EUA of our #COVID19 vaccine to incl. in children 6mths - <5yrs following a request from the #FDA. We plan to share these data with the #EMA and other regulatory authorities. investors.biontech.de/news-releases/…
    Image
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Jan 6, 2023
    We today announced signing an MoU with the UK government to accelerate trials for personalized #mRNA #immunotherapies. Our objective: providing personalized cancer therapies for up to 10k patients by end 2030 in clinical trials or as authorized treatments. investors.biontech.de/news-releases/…
    Image
    203K
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Mar 19, 2021
    Congratulations to Ugur Sahin & Özlem Türeci for having been awarded the Order of Merit of the Federal Republic of Germany by President Frank-Walter Steinmeier & Chancellor Angela Merkel. The award shows the difference that innovation and science can make. bit.ly/3cLvk12
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Aug 27, 2021
    Invited by the @KenupFoundation, President @PaulKagame of Rwanda, President @Macky_Sall of Senegal, & @EU_Commission President @vonderleyen met #BioNTech CEO Uğur Şahin to discuss the establishment of vaccine manufacturing capabilities in the AU. investors.biontech.de/news-releases/…
    Image
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Dec 26, 2020
    All 27 EU Member States received their first batches of our #COVID19 vaccine. The picture below shows a couple of them. What a great day!
    Image
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Nov 20, 2020
    We are submitting our first request for an #EUA in the U.S. for vaccine candidate #BNT162b2 against #covid19. We look forward to continuously providing data to various regulatory authorities as part of our rolling review process – including the @EMA_News. bit.ly/36RBUjA
    Image
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Mar 26, 2021
    The first batches of #mRNA vaccines manufactured at Marburg are expected to be delivered in the second half of April. The @EMA_News has approved the commercial use of drug substance and drug product manufactured at the site. bit.ly/3coajKM
    Image
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Oct 15, 2021
    We've submitted data supporting the vaccination of children 5 to <12 yrs of age with our #Covid19 vaccine to the @EMA_News for a variation of the Conditional Marketing Authorization. The same data have been submitted to the @US_FDA & others. investors.biontech.de/press-releases
    Image
  • user avatar
    BioNTech SE
    @BioNTech_Group
    Dec 12, 2020
    Our #vaccine candidate #BNT162b2 has been authorized by the @US_FDA for emergency use in the U.S. We stand ready to distribute our vaccine following authorizations or approvals from other regulatory authorities around the globe.
    Image